Targeting Cancer Through Thymoquinone: From Molecular Mechanisms to Clinical Prospects

Area of Science:

• Natural compounds and cancer research
• Pharmacology and therapeutic potential
• Immunology and cancer therapy

Background:

• Nigella sativa's active compound, thymoquinone (TQ), demonstrates significant anticancer properties in preclinical studies.
• Cancer treatment faces challenges including chemoresistance and side effects, necessitating novel therapeutic strategies.
• Understanding TQ's multifaceted mechanisms is crucial for its potential clinical application.

Purpose of the Study:

• To review the diverse anticancer mechanisms of thymoquinone (TQ).
• To explore TQ's potential in overcoming chemoresistance and enhancing conventional cancer therapies.
• To identify challenges and suggest future directions for TQ research, including clinical trials.

Main Methods:

• Comprehensive literature review of studies on thymoquinone's anticancer effects.
• Analysis of TQ's impact on cancer cell proliferation, apoptosis, inflammation, and immune response.
• Examination of TQ's role in targeting cancer stem cells, the tumor microenvironment, and epigenetic regulation.

Main Results:

• TQ exhibits anticancer activities including inhibiting proliferation, inducing apoptosis, reducing inflammation, and modulating immune responses.
• TQ demonstrates potential in overcoming chemoresistance and synergizing with chemotherapy, radiation, and immunotherapy in preclinical models.
• TQ influences cancer stem cells, the tumor microenvironment, and epigenetic modifications, suggesting broad-spectrum activity.

Conclusions:

• Thymoquinone (TQ) presents a promising natural compound for cancer therapy with diverse mechanisms of action.
• Enhancing TQ's bioavailability and conducting clinical trials are essential next steps for its therapeutic development.
• TQ holds potential to improve cancer treatment efficacy and tolerability, warranting further investigation.